• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microbial mRNAs in Bovine Milk Exosomes Are Bioavailable in Humans and Mice and Increase Survival of Mice Challenged with Influenza A (OR12-07-19)

tetano

Editor, Senior Moderator
Curr Dev Nutr. 2019 Jun 13;3(Suppl 1). pii: nzz049.OR12-07-19. doi: 10.1093/cdn/nzz049.OR12-07-19. eCollection 2019 Jun.
[h=1]Microbial mRNAs in Bovine Milk Exosomes Are Bioavailable in Humans and Mice and Increase Survival of Mice Challenged with Influenza A (OR12-07-19).[/h] Wu D[SUP]1[/SUP], Zhou F[SUP]1[/SUP], Upadhyaya B[SUP]1[/SUP], Shu J[SUP]1[/SUP], Mutai E[SUP]1[/SUP], Cui J[SUP]1[/SUP], Zempleni J[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Objectives:[/h] Exosomes are natural nanoparticles that facilitate cell-to-cell communication by transferring RNAs from donor to recipient cells. Previous studies focused on microRNA cargos and disregarded mRNAs. Exosomes and RNA cargos may be absorbed from milk. RNAs elicit antiviral responses by activating interferon type I (IFN) and NF-kappa B (NF-kB) signaling (Figure 1A).To assess whether 1) bovine milk exosomes (BME) contain microbial mRNAs, 2) microbial mRNAs are bioavailable in humans and mice, and 3) microbial mRNAs activate antiviral responses in reporter cells and mice.
[h=4]Methods:[/h] The mRNA content in BME was assessed by RNA-sequencing. mRNA bioavailability was assessed by RNA-sequencing analysis of human plasma before and 4 h after consumption of 1 L milk and by administering BME transfected with synthetic, fluorophore (IRDye)-labeled Pseudomonas fluorescens capB mRNA to Balb/c mice by oral gavage. (capB mRNA was abundantly expressed in all BME samples sequenced.) Antiviral responses were assessed using liposomes loaded with capB mRNA and cultured with IFN and NF-kB J774 reporter macrophages, and by survival curves of mice fed BME-free or BME-sufficient diets and challenged with influenza A virus. Unpaired t-test was used for statistical analyses; P < 0.05 was considered significant.
[h=4]Results:[/h] About 50% of the mRNA-sequencing reads in BME were non-bovine; after contig assembly, up to two thirds of the non-bovine reads mapped to microbial mRNAs (Figure 1B). IRDye-capB mRNA accumulated in murine intestinal mucosa and liver (and perhaps brain) 6 h and 24 h, respectively, after oral gavage (Figure 2). Microbial mRNAs, including 55 and 36 mRNAs from P. fluorescens and E. coli were detected in human plasma after but not before a milk meal (Tables 1, 2). capB mRNA-loaded liposomes activated NF-kB and IFN signaling in reporter macrophages (Figure 3A). C57BL/6 mice fed a BME-depleted diet died within 11 days of influenza A challenge whereas controls fed a BME-sufficient diet survived (Figure 3B).
[h=4]Conclusions:[/h] This is the first report to suggest a novel interaction between microbiome and hosts: microbial mRNAs in BME are bioavailable, activate antiviral IFN and NF-kB pathways and increase resistance to influenza A.
[h=4]Funding Sources:[/h] NIFA, NIH, Gates Foundation, PureTech Health, USDA Hatch & Multistate. J.Z. is a consultant for PureTech.
[h=4]Supporting Tables Images and/or Graphs:[/h]


PMID: 31223866 PMCID: PMC6574010 DOI: 10.1093/cdn/nzz049.OR12-07-19
Free PMC Article
 
Back
Top Bottom